RDFa 1.0 has been greeted mostly with enthusiasm, but there has been some criticism.

MULTIDISCIPLINARY science is all the rage these days. Even so, the overlap between archaeology and pharmacology is not, at first sight, obvious.

Often, after an initial frenzy on an IPO, the stocks later fall below their initial offering price.